• OPEN AN ACCOUNT
Indian Indices
Sensex
76,570.35 -373.93
( -0.49%)
Global Indices
Nasdaq
52,794.59 -412.31
(-0.77%)
Dow Jones
7,653.60 -53.54
(-0.69%)
Hang Seng
64,415.54 -1,799.80
(-2.72%)
Nikkei 225
10,761.93 -27.35
(-0.25%)
Forex
USD-INR
95.24 -0.24
(-0.25%)
EUR-INR
110.49 -0.08
(-0.07%)
GBP-INR
128.99 -0.20
(-0.15%)
JPY-INR
0.60 0.00
(-0.03%)

EQUITY - MARKET SCREENER

Indo US Bio-Tech Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
541304
INE250Z01010
46.1460203
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
INDOUS
13.59
155.6
EPS(TTM)
Face Value()
Div & Yield %
5.71
10
0
 

the ramco cements ltd
Epigral consolidated net profit declines 6.84% in the March 2026 quarter
May 02,2026
Net profit of Epigral declined 6.84% to Rs 80.95 crore in the quarter ended March 2026 as against Rs 86.89 crore during the previous quarter ended March 2025. Sales rose 17.29% to Rs 736.16 crore in the quarter ended March 2026 as against Rs 627.63 crore during the previous quarter ended March 2025.

For the full year,net profit declined 7.19% to Rs 331.97 crore in the year ended March 2026 as against Rs 357.69 crore during the previous year ended March 2025. Sales declined 0.90% to Rs 2527.18 crore in the year ended March 2026 as against Rs 2550.13 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales736.16627.63 17 2527.182550.13 -1
OPM %22.7727.62 -22.4027.87 -
PBDT151.23165.28 -9 509.05673.65 -24
PBT109.54131.33 -17 340.76541.09 -37
NP80.9586.89 -7 331.97357.69 -7